Hot and Ready
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What did you learn from them?
The last publication we were in was NATURE. If our data results are as good as Missling portrays then if I owned a publication I would want to be the one doing the review, wouldn't you? We are talking about a brand new paradigm in CNS disease.
Now if I looked and someone was distorting the results I would not want to go near it with a 10 ft pole.
I truly want this to be approved and reach and help millions of people. Id like to see a share price of $2000 in 10 years. But this void in communication makes it seem like he is hiding something. Im sure BMS approached us on schizophrenia.
Hit piece out on SA. Myriam Alvarez.
Or window dressing.
I think he did a fairly good job letting the analyst feed him softballs.
I think he should have taken the 371 conversation deeper on Dementia and dropped MJFF on PD
But he was credible. I don't believe I just said that.
Don't count on it.
Joe Seriously? 1 out of 1000.
More spaghetti to throw against the wall
3 million in US 1% of population.
I believe Missling told them to get lost and never acknowledged the shareholders.
Can George get on Redditt and drive them cuckoo about Blacarsimine. It would do more good than here. Better ROI of his time.
We need to get AVXL in front of them
Might want to real time Nasdaq. Yahoo...lol
No it's the CEOs decision.
PW don't deflect...WHERE IS THE DATA? IT IS AVAILABLE, IT IS MATERIAL AND THE LACK OF RELEASE IS CAUSING HARM TO SHARHOLDERS.
I COME FROM A FINANCIAL SERVICES BACKROUND NOT BP.
I COME FROM AN OUTSTANDING COMPANY THAT WAS TRANSPERNT AND ACCOUNTABLE.
WHERE IS THE EFFING DATA!
PW WHERE IS THE DATA? WHERE IS THE DATA. BS ON THE DARK PERIOD FOR PEER REVIEW. ITS COMPLETED ITS MATERIAL AND SHAREHOLDERS SHOULD HAVE SEEN IT BY NOW.
FDA HAS ONLY ADAS-COG REQUIREMENT NOW. WHERE IS THE DAMM DATA. NO MORE BS WE GOT THIS. WE PAID DEARLY TO SEE THE DATA. WE OWN ANAVEX STOCK NOT MISSLING STOCK.
Agreed. We need to get Toutains position filled as a succession pla n should something happen to Fritzy to protect shareholders.
If not as shareholders we should be able to take life insurance out on Missling since we have and insurable interest.
Agreed Jerry. I heard the same thing. Some goof named Darby said I was wrong. Latest CC he said this year for EMA. Then stated FDA lowered their biomarker standards and could possibly file simultaneously. But I bet he waits for RETT retrial.
PW you might not of listened to the call yesterday.
Normally analyst targets are for a year.
When Missling announced EMA he said the plan would be as ealy as possible in 2024. Yesterday he said by the end of the year more than once.
Remember Jin was on board in Jan of 23.
Yesterday he hinted because of new FDA rules using 1 biomarker, there could be multiple submissions.
Now we know if it takes EMA 7 submission a year then how could they submit to FDA at the same time.
So $15.00 is a annual target and I doubt they get EMA in by December.
I've been an investor for 50 years. I've never seen such malfeasance and lack of transparency in all those years. I might be better off in the lawsuit at $31.50 plus punitive damages if I'm looking at $15.00.
just bringing reality to the WGT and Fritzy fans. What has he accomplished in 8 years that would allow him to have that kind of option load.
Anavex Life Sciences (AVXL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTrading reiterated a Buy rating on the stock and has a $15.00 price target.
Would Toutain leave for a better package knowing what coming down the pike? There’s definitely more to his departure. High level people don’t leave at a time like this if they don’t have to.
Could you be number two to the least qualified CEO in NYC? Maybe he has a shot at the big job in a year or to there. I couldn't work for numbnuts as #2 that's for sure. Not sure how many here worked in the rarefied air but they did take Misslings CBOD job away for a reason. He is not a Senior Guy.
Go back to his original announcement.
Well instead of calling my comment a reach why not tell us what you heard.
I heard at least twice, this year. It is 7 month process which started I November.
You're new here aren't you.
EMA slipped from 1st H24 no we are at this year. He sucks.
He is ineffective. Zero analysts on the call just junior placeholders
that's crap. Missling controls 7m shares that's plenty for a guy with no results.
Too bad someone can't hack the CC and put in Serious hardball questions.
ie
Can the shareholders have an update on EVERYTHING.
RETT STATUS
PDD TRIAL STATUS
PROGRESS WITH FDA STATUS
FRAGILE X STATUS
RARE DISEASE SECRET STATUS
WHY DO THEY NEED GOLDEN PARACHUTES WHEN WE HAVE NO REVENUE
WHY TOUTAIN LEFT AND PLAN FOR SUCCESSION.
If you follow George you are nuts based on his track record. 2 things move the stock. Approval or Buyout.Period.
Nidan I know you are long. However, there is a method called short. Anavex is a "Event" driven stock. When there is garunteed long spaces of time traders have a garunteed safer period period of time to short.
Due to Missling's (IB background) poor communication, poor planning, poor trial creation, he leaves the shareholders open to be slaughtered.
Look at ANVS as an example. Unless a buyout goes down....it's as easy as printing money.
So he will use schizophrenia results for 371 MOA as he had planned to use Rett for 273.
The schizophrenia trial ends on 5/28?
What was the price of Karunna before BMS paid $330 per share?
Miracle drug was put out there by the 7 million share man.If BMS can buy Karunan for $330 per share we should get $500 in a buyout. Missling's ego will block that.
I think this is why the Board took Missling out if the Chair role. If a CEO is approached on a buyout possibility he MUST notify the Chairman asap. Im sure he would try to block any buyout.
I would hope BLACKROCK is tired of the unprofessional behavior of the CEO. Pretty sure Vangaurd is too.
7M shares are ludicrous
Wouldn't a buyout be great! No more incoherent communications.
Is that why Toutain left?
Missling has always said partner large INDs and keep pediatric rare disease. Messianic complex.